Pfizer to Invest $500M in State-of-the-Art Gene Therapy Facility in North Carolina
Shots:
- Pfizer plans to invest half-billion dollars for the construction of its state-of-the-art gene therapy manufacturing facility in Sanford- North Carolina which is expected to support its ongoing R&D investments in gene therapy- like its R&D sites in Chapel Hill and Kit Creek
- The investment will expand Pfizer’s footprints in Sanford- strengthen its gene therapy manufacturing technology and its ability to develop both clinical- and commercial-scale quantities of gene therapies for patients with rare diseases across the globe
- Pfizer’s Sanford facility will manufacture gene therapies and its vaccine portfolio including Prevnar 13 and other vaccines currently present in Pfizer’s pipeline and will provide ~300 new jobs
Click here to read full press release/ article | Ref: Pfizer | Image: Behance
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com